XML 28 R16.htm IDEA: XBRL DOCUMENT
v3.24.2.u1

Other Balance Sheet Components | 6 Months Ended
--- | ---
Jun. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract] |
Other Balance Sheet Components | 9. Other Balance Sheet Components Accounts Receivable, net Accounts receivable, net, as of June 30, 2024 and December 31, 2023 consisted of the following (in millions):
|  | June 30, |  | December 31,
|  | 2024 |  | 2023
Accounts receivable |  | $ | 492 |  |  | $ | 1,584 |
Less: Wholesalers chargebacks, discounts and fees |  | (329) |  |  | (692) |
Accounts receivable, net |  | $ | 163 |  |  | $ | 892 |
Prepaid Expenses and Other Current Assets Prepaid expenses and other current assets, as of June 30, 2024 and December 31, 2023 consisted of the following (in millions):
|  | June 30, |  | December 31,
|  | 2024 |  | 2023
Prepaid services |  | $ | 184 |  |  | $ | 182 |
Down payments and prepayments related to manufacturing and materials |  | 111 |  |  | 168 |
Income tax receivable |  | 105 |  |  | 19 |
Collaboration receivable |  | 73 |  |  | 61 |
Interest receivable |  | 56 |  |  | 59 |
Value added tax receivable |  | 26 |  |  | 50 |
Prepaid income tax |  | 25 |  |  | — |
Other current assets |  | 31 |  |  | 88 |
Prepaid expenses and other current assets |  | $ | 611 |  |  | $ | 627 |
Other Non-Current Assets Other non-current assets, as of June 30, 2024 and December 31, 2023 consisted of the following (in millions):
|  | June 30, |  | December 31,
|  | 2024 |  | 2023
Down payments and prepayments, non-current |  | $ | 321 |  |  | $ | 342 |
Inventory, non-current(1) |  | 161 |  |  | 170 |
Goodwill |  | 52 |  |  | 52 |
Finite-lived intangible asset |  | 42 |  |  | 44 |
Equity investments |  | 31 |  |  | 66 |
Other |  | 34 |  |  | 11 |
Other non-current assets |  | $ | 641 |  |  | $ | 685 |
_______ (1)Consisted of raw materials with an anticipated consumption beyond one year. Accrued Liabilities Accrued liabilities, as of June 30, 2024 and December 31, 2023 consisted of the following (in millions):
|  | June 30, |  | December 31,
|  | 2024 |  | 2023
Provisions related to product sales (Note 3) |  | $ | 554 |  |  | $ | 556 |
Compensation-related |  | 187 |  |  | 245 |
Manufacturing |  | 119 |  |  | 167 |
Other external goods and services |  | 109 |  |  | 137 |
Clinical trials |  | 96 |  |  | 175 |
Property, plant and equipment |  | 93 |  |  | 94 |
Development operations |  | 90 |  |  | 140 |
Raw materials |  | 42 |  |  | 27 |
Commercial |  | 32 |  |  | 56 |
Royalties |  | 10 |  |  | 122 |
Loss on future firm purchase commitments(1) |  | 1 |  |  | 79 |
Accrued liabilities |  | $ | 1,333 |  |  | $ | 1,798 |
______ (1)Related to losses that are expected to arise from firm, non-cancellable, commitments for future raw material purchases (Note 7). Other Current Liabilities Other current liabilities, as of June 30, 2024 and December 31, 2023 consisted of the following (in millions):
|  | June 30, |  | December 31,
|  | 2024 |  | 2023
Lease liabilities - operating (Note 10) |  | $ | 25 |  |  | $ | 25 |
Other |  | 17 |  |  | 41 |
Other current liabilities |  | $ | 42 |  |  | $ | 66 |
Deferred Revenue The following table summarizes the activities in deferred revenue for the six months ended June 30, 2024 (in millions):
|  | December 31, 2023 |  | Additions |  | Deductions |  | June 30, 2024
Product sales |  | $ | 613 |  |  | $ | 196 |  |  | $ | (69) |  |  | $ | 740 |
Grant revenue |  | 4 |  |  | — |  |  | — |  |  | 4 |
Collaboration revenue |  | 34 |  |  | 6 |  |  | (7) |  |  | 33 |
Licensing and royalty revenue |  | — |  |  | 20 |  |  | — |  |  | 20 |
Total deferred revenue |  | $ | 651 |  |  | $ | 222 |  |  | $ | (76) |  |  | $ | 797 |

X
- References No definition available. + Details
Name: | us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 210 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/210/tableOfContent + Details
Name: | us-gaap_SupplementalBalanceSheetDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration